Our understanding of neuronal cell types has advanced considerably with the publication of single cell atlases, mapping hundreds of putative cell types across brain areas. Characterizing these cell types is a key step towards understanding how the brain works and dysfunctions. Marker genes play an essential role for experimental validation and computational analyses such as physiological characterization through pathway enrichment, annotation, and deconvolution. However, a framework for quantifying marker replicability and picking replicable markers is currently lacking, particularly for cell types at the finest resolution. Here, using high quality data from the Brain Initiative Cell Census Network (BICCN), we systematically investigate marker replicability for the proposed BICCN cell types. We show that, due to dataset-specific noise, we need to combine 5 datasets to obtain robust differentially expressed (DE) genes, particularly for rare populations and lowly expressed genes. We find that two standard DE statistics, fold change and AUROC, can be combined to select the best markers, ranging from highly sensitive to highly specific. Finally, we show that a meta-analytic selection of markers improves performance in downstream computational tasks: cluster separability, annotation and deconvolution. Based on these tasks, we estimate that 10 to 200 meta-analytic markers provide optimal performance, offering an interpretable and robust description of cell types. Replicable marker lists condense single cell atlases into generalizable and accessible information about cell types, opening avenues for multiple downstream applications, including cell type annotation, selection of gene panels and bulk data deconvolution.